Gv 2017 Gp, L.l.c. - Net Worth and Insider Trading
Gv 2017 Gp, L.l.c. Net Worth
The estimated net worth of Gv 2017 Gp, L.l.c. is at least $62 Million dollars as of 2024-05-11. Gv 2017 Gp, L.l.c. is the of Verve Therapeutics Inc and owns about 10,368,489 shares of Verve Therapeutics Inc (VERV) stock worth over $62 Million. Details can be seen in Gv 2017 Gp, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gv 2017 Gp, L.l.c. has not made any transactions after 2022-11-04 and currently still holds the listed stock(s).
Transaction Summary of Gv 2017 Gp, L.l.c.
Gv 2017 Gp, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gv 2017 Gp, L.l.c. owns 4 companies in total, including Arcus Biosciences Inc (RCUS) , GitLab Inc (GTLB) , and Decibel Therapeutics Inc (DBTX) among others .
Click here to see the complete history of Gv 2017 Gp, L.l.c.’s form 4 insider trades.
Insider Ownership Summary of Gv 2017 Gp, L.l.c.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RCUS | Arcus Biosciences Inc | 2018-03-14 | 10 percent owner |
| GTLB | GitLab Inc | 2021-10-13 | 10 percent owner |
| DBTX | Decibel Therapeutics Inc | 2021-02-11 | 10 percent owner |
 | | 2022-11-04 | 10 percent owner |
Gv 2017 Gp, L.l.c. Latest Holdings Summary
Gv 2017 Gp, L.l.c. currently owns a total of 1 stock. Gv 2017 Gp, L.l.c. owns 10,368,489 shares of Verve Therapeutics Inc (VERV) as of November 4, 2022, with a value of $62 Million.
Latest Holdings of Gv 2017 Gp, L.l.c.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2022-11-04 | 10,368,489 | 6.01 | 62,314,619 |
Holding Weightings of Gv 2017 Gp, L.l.c.
Gv 2017 Gp, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Gv 2017 Gp, L.l.c. has made a total of 3 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Verve Therapeutics Inc is the sale of 97,166 shares on November 4, 2022, which brought Gv 2017 Gp, L.l.c. around $3 Million.
Insider Trading History of Gv 2017 Gp, L.l.c.
- 1
Gv 2017 Gp, L.l.c. Trading Performance
Gv 2017 Gp, L.l.c. Ownership Network
Gv 2017 Gp, L.l.c. Owned Company Details
What does Arcus Biosciences Inc do?
Who are the key executives at Arcus Biosciences Inc?
Gv 2017 Gp, L.l.c. is the 10 percent owner of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include See Remarks Jennifer Jarrett , director & 10 percent owner & President Juan C. Jaen , and 10 percent owner Gilead Sciences Inc .
Arcus Biosciences Inc (RCUS) Insider Trades Summary
Over the past 18 months, Gv 2017 Gp, L.l.c. made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 223,626 shares made by Jennifer Jarrett , a net sale of 38,443 shares made by Juan C. Jaen , and a net sale of 8,506 shares made by Goeltz Ii Robert C. .
In summary, during the past 3 months, insiders sold 110,657 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 110,657 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.
Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcus Biosciences Inc Insider Transactions
Gv 2017 Gp, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Gv 2017 Gp, L.l.c.. You might contact Gv 2017 Gp, L.l.c. via mailing address: 1600 Amphitheatre Parkway, Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
